Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury - PubMed (original) (raw)
Review
. 1998 Mar 30;104(3A):23S-29S; discussion 41S-42S.
doi: 10.1016/s0002-9343(97)00207-6.
Affiliations
- PMID: 9572317
- DOI: 10.1016/s0002-9343(97)00207-6
Review
Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury
M R Griffin. Am J Med. 1998.
Abstract
Nonaspirin, nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most frequently used drugs in many countries. Use of the majority of NSAIDs increases with age, primarily for symptoms associated with osteoarthritis and other chronic musculoskeletal conditions. Population-based studies have shown that, on any given day, 10-20% of elderly people (> or = 65 years old) have a current or recent NSAID prescription. Over a 6-month period in Alberta, Canada, 27% of elderly people were prescribed NSAIDs. Furthermore, in Tennessee (USA), 40% of elderly people received at least one NSAID prescription annually, and 6% had NSAID prescriptions for > 75% of the year. NSAIDs cause a wide variety of side-effects. The most clinically important side-effects are upper gastrointestinal tract dyspepsia, peptic ulceration, hemorrhage, and perforation, leading to death in some patients. Gastrointestinal side-effects are common; the most common NSAID-associated side-effect is epigastric pain/indigestion. Gastrointestinal side-effects are also a frequent reason both for withdrawal of NSAIDs and for co-treatment with another drug. Indeed, in two population-based studies of people aged > or = 65 years, the use of agents to prevent peptic ulcers or relieve dyspepsia was nearly twice as common in regular NSAID users (20-26%) than in non-NSAID users (11%). In Alberta, Canada, it has been estimated that NSAID use accounts for 28% of all prescriptions for anti-ulcer drugs in people aged at least 65 years. Many studies have now shown that NSAIDs increase the risk of peptic ulcer complications by 3-5-fold, and in several different populations it has been estimated that 15-35% of all peptic ulcer complications are due to NSAIDs. In the United States alone, there are an estimated 41,000 hospitalizations and 3,300 deaths each year among the elderly that are associated with NSAIDs. Factors that increase the risk of serious peptic ulcer disease include older age, history of peptic ulcer disease, gastrointestinal hemorrhage, dyspepsia, and/or previous NSAID intolerance, as well as several measures of poor health.
Similar articles
- Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
Voutilainen M, Mäntynen T, Färkkilä M, Juhola M, Sipponen P. Voutilainen M, et al. Scand J Gastroenterol. 2001 Aug;36(8):817-21. doi: 10.1080/003655201750313333. Scand J Gastroenterol. 2001. PMID: 11495076 - The epidemiology of nonsteroidal anti-inflammatory drugs.
Tenenbaum J. Tenenbaum J. Can J Gastroenterol. 1999 Mar;13(2):119-22. doi: 10.1155/1999/361651. Can J Gastroenterol. 1999. PMID: 10203429 Review. - Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta.
Hogan DB, Campbell NR, Crutcher R, Jennett P, MacLeod N. Hogan DB, et al. CMAJ. 1994 Aug 1;151(3):315-22. CMAJ. 1994. PMID: 8039085 Free PMC article. - NSAID-associated dyspepsia and ulcers: a prospective cohort study in primary care.
Hollenz M, Stolte M, Leodolter A, Labenz J. Hollenz M, et al. Dig Dis. 2006;24(1-2):189-94. doi: 10.1159/000090321. Dig Dis. 2006. PMID: 16699277 - Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Induced Dyspepsia.
Yap PR, Goh KL. Yap PR, et al. Curr Pharm Des. 2015;21(35):5073-81. doi: 10.2174/1381612821666150915105738. Curr Pharm Des. 2015. PMID: 26369685 Review.
Cited by
- Efficacy of a natural mineral complex in North American adults with osteoarthritis of the knee: a randomized double-blind placebo-controlled study.
Evans M, Wilson D, Guthrie N. Evans M, et al. Open Access Rheumatol. 2014 Oct 3;6:91-103. doi: 10.2147/OARRR.S71161. eCollection 2014. Open Access Rheumatol. 2014. PMID: 27790038 Free PMC article. - Safety and efficacy of oral nonsteroidal anti-inflammatory drugs in patients with rheumatoid arthritis : a six-month randomised study.
Shi W, Wang YM, Li LS, Yan M, Li D, Chen NN, Chen BY. Shi W, et al. Clin Drug Investig. 2004;24(2):89-101. doi: 10.2165/00044011-200424020-00004. Clin Drug Investig. 2004. PMID: 17516695 - A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.
Sengupta K, Alluri KV, Satish AR, Mishra S, Golakoti T, Sarma KV, Dey D, Raychaudhuri SP. Sengupta K, et al. Arthritis Res Ther. 2008;10(4):R85. doi: 10.1186/ar2461. Epub 2008 Jul 30. Arthritis Res Ther. 2008. PMID: 18667054 Free PMC article. Clinical Trial. - Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen.
Deplano A, Karlsson J, Svensson M, Moraca F, Catalanotti B, Fowler CJ, Onnis V. Deplano A, et al. J Enzyme Inhib Med Chem. 2020 Dec;35(1):815-823. doi: 10.1080/14756366.2020.1743283. J Enzyme Inhib Med Chem. 2020. PMID: 32200655 Free PMC article. - Rebamipide helps defend against nonsteroidal anti-inflammatory drugs induced gastroenteropathy: a systematic review and meta-analysis.
Zhang S, Qing Q, Bai Y, Mao H, Zhu W, Chen Q, Zhang Y, Chen Y. Zhang S, et al. Dig Dis Sci. 2013 Jul;58(7):1991-2000. doi: 10.1007/s10620-013-2606-0. Epub 2013 Feb 28. Dig Dis Sci. 2013. PMID: 23456504 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical